How the peptide names fit into research groups
Research groups help you navigate related scientific questions. They are broad catalogue categories: two entries in one group can still differ in sequence, mechanism, experimental model and formulation.
Metabolic peptides: retatrutide and tirzepatide
Retatrutide is investigated across GLP-1, GIP and glucagon receptors. Tirzepatide acts at GIP and GLP-1 receptors. Both appear in metabolic research discussions, but their receptor profiles differ. The metabolic peptide research overview explains those pathways alongside related molecules discussed in the literature.
A primary retatrutide clinical study provides scientific background for the triple-receptor approach. Study results describe the trial material and population; they do not characterise an Aurelis vial.
Tissue and matrix research: BPC-157, TB-500 and GHK-Cu
BPC-157 appears in preclinical tissue-response investigations. GHK-Cu is a copper-binding complex studied in fibroblast and extracellular-matrix biology. TB-500 is a thymosin-beta-4-related research name for which the sequence is especially important. These are separate material identities, even when a catalogue places them together.
Selected primary sources include a BPC-157 rat tendon-fibroblast experiment, a GHK-Cu fibroblast-culture study and analytical work on a TB-500 peptide fragment. Match the studied molecule to the identity of the material in your enquiry.
Neuroscience research: Semax and Selank
Semax and Selank are distinct heptapeptides with ACTH-related and tuftsin-related origins respectively. Their literature includes neurotrophin and neurotransmission questions. Our Semax vs Selank guide compares the research focus and explains why a 10 mg vial listing and a nasal-spray specification describe different attributes.
Inflammatory signalling: KPV
KPV is the Lys-Pro-Val tripeptide associated with alpha-MSH. Primary cell and mouse-model work explores intestinal epithelial uptake and inflammatory signalling. This makes it an entry to review by experimental pathway and material specification.
Cellular and mitochondrial research: MOTS-C, SS-31 and Epitalon
MOTS-C is a mitochondrial-derived peptide associated with cellular energy and metabolic adaptation. SS-31, also called elamipretide, concerns mitochondrial membrane and cardiolipin biology. Epitalon is a tetrapeptide discussed in telomerase and cellular-ageing research. This group is a navigation aid rather than a shared mechanism: energy sensing, membrane biology and telomere maintenance are different study areas.
Endocrine signalling: tesamorelin, sermorelin and peptide pairings
Tesamorelin and Sermorelin relate to growth hormone-releasing pathways. The Ipamorelin + CJC (no DAC) entry is a pairing enquiry with additional composition questions. For this pairing, specify the exact CJC-related sequence and the amount of each component before comparing totals.
Peptide blends are a separate layer of comparison
GLOW, Wolverine and KLOW are blend names. GLOW lists three components, while Wolverine lists two. KLOW needs its complete current specification confirmed. The peptide blends comparison records the source-listed amounts and explains the unresolved totals in detail.
A standalone compound profile provides background on a named ingredient. For a blend, you also need the full combination identity, component amounts, combined total and analytical results for the selected batch.
How to read 10 mg, 50 mg and other catalogue strengths
The Aurelis mg values describe listed content per unit. For example, a GHK-Cu 50 mg listing and a GHK-Cu 100 mg listing are two content specifications. The number by itself does not define a liquid concentration, a delivered amount from a device or an experimental protocol.
A finished liquid or spray also needs a fill volume and formulation specification. A pen or cartridge adds container and device attributes. Use the format guide to frame those questions and the quality guide to distinguish identity, analytical purity and measured content.
Turn the list into a clear local-stock enquiry
Start with the full catalogue name, listed content and required presentation. Add the destination country, any required batch documentation and any composition detail that needs clarification. Aurelis holds stock in Australia, Canada and the USA; availability is confirmed for the specific material, strength and format in your enquiry.
For a single compound, one name and strength provide a clear starting point. For a blend, request the complete component sheet. For a nasal format, include the finished formulation and pump specification. These details help our team respond to the actual material you need.
Send a catalogue enquiry or explore the searchable peptide catalogue.